Literature DB >> 24566395

Serial FDG PET/CT in autoimmune encephalitis with faciobrachial dystonic seizures.

Albrecht Kunze1, Robert Drescher, Katharina Kaiser, Martin Freesmeyer, Otto W Witte, Hubertus Axer.   

Abstract

Autoimmune encephalitis (AE) is increasingly recognized as a nonparaneoplastic disorder with autoantibodies to neuronal proteins. Although MRI is frequently unremarkable, PET imaging might contribute to identification of affected brain regions in distinct AE. We report on serial FDG PET in a 72-year-old man with particular AE subtype, with potassium channel complex antibodies and prodromal stage with dystonic seizures. Serial FDG PET/CT revealed that besides limbic structures, basal ganglia are centrally involved and presumably play a key role in the generation of dystonic seizures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566395     DOI: 10.1097/RLU.0000000000000372

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  The Detection of Invisible Abnormal Metabolism in the FDG-PET Images of Patients With Anti-LGI1 Encephalitis by Machine Learning.

Authors:  Jian Pan; Ruijuan Lv; Guifei Zhou; Run Si; Qun Wang; Xiaobin Zhao; Jiangang Liu; Lin Ai
Journal:  Front Neurol       Date:  2022-05-30       Impact factor: 4.086

2.  Research on the Mechanism of HMGB1 Regulating Autoimmune Encephalomyelitis by Regulating NF-κB.

Authors:  Lijuan Liu; Jingtao Pang; Hui Yuan; Shengnu Qiu; Wei Zhang; Zhenzhu Shang; Xiaoting Liu
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

3.  Cognitive Impairments Preceding and Outlasting Autoimmune Limbic Encephalitis.

Authors:  Robert Gross; Jennifer Davis; Julie Roth; Henry Querfurth
Journal:  Case Rep Neurol Med       Date:  2016-01-10

Review 4.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.